Pharmaceutical Industry Information Portal

HomeNews

News

Single-dose Sputnik Light vaccine registered in Kazakhstan

Sputnik Light demonstrated 79.4% efficacy according to analyzed data taken from 28 days after the injection was administered. In February 2021, Kazakhstan approved the two-dose Sputnik V vaccine.

WTO issues joint indicative list of critical inputs for COVID-19 vaccines

The WTO Secretariat has published an indicative list compiling information on the critical inputs for the manufacturing, distributing and administering of COVID-19 vaccines.

RDIF and Serum Institute of India to start production of Sputnik vaccine in September

The first batch of Sputnik vaccine is expected to be produced at SII’s facilities in September. The parties intend to produce over 300 million doses of the vaccine in India per year.

R-Pharm and Frontier Biotech will provide Russia with a new drug for the treatment of HIV

Aikening™ is a new fusion inhibitor. It is the first and only long-acting injectable (as IV infusion QW) available as a dual therapy for treatment-experienced patients with HIV-1 replication.

Sputnik V vaccine effective against new variants of coronavirus

Sputnik V pioneered the vaccine cocktail approach with two shots. The tests conducted by the Gamaleya Center have demonstrated validity of this approach.

SINOVAC Enters Into Agreement to Supply CoronaVac® to COVAX

In total, up to 380 million doses of CoronaVac® will be available to both self-financing participants of the Facility as well as those supported by the Gavi COVAX AMC.
spot_img

Expert Articles

spot_img